Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation

Citation
El. Nelson et al., Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation, FASEB J, 13(14), 1999, pp. 2021-2030
Citations number
46
Categorie Soggetti
Experimental Biology
Journal title
FASEB JOURNAL
ISSN journal
08926638 → ACNP
Volume
13
Issue
14
Year of publication
1999
Pages
2021 - 2030
Database
ISI
SICI code
0892-6638(199911)13:14<2021:COHDCE>2.0.ZU;2-M
Abstract
Dendritic cells (DCs) are potent antigen presenting cells reported to under go irreversible functional 'maturation' in response to inflammatory signals such as TNF-alpha. The current paradigm holds that this DC maturation even t is required for full functional capacity and represents terminal differen tiation of this cell type, culminating in apoptotic cell death. This provid es a possible mechanism for avoiding dysregulated immunostimulatory activit y, but imposes constraints on the capacity of DCs to influence subsequent i mmune responses and to participate in immunological memory. We report that the cell surface and functional effects induced by TNF-alpha are reversible and reinducible. These effects are accompanied by a concordant modulation of cytokine mRNA expression that includes the induction of proinflammatory factors (IL-15, IL-12, LT-a!, LT-beta, TNF-alpha, RANTES) which is coincide nt with the down-regulation of counter-regulatory cytokines (IL-10, TGF-bet a 1, TGF-beta 2, IL-1 RA, MCP-1). The resultant net effect is a dendritic c ell activation state characterized by a transient proinflammatory posture. These results demonstrate that 1) human DCs do not undergo terminal 'matura tion' in response to TNF-alpha, 2) DC phenotypes are more pleiotropic than previously thought, and 3) DCs are potential immunoregulatory effector cell s with implications for control of immune responses in both in vivo and in vitro systems.-Nelson, E. L., Strobl, S., Subleski, J., Prieto, D., Kopp, W . C., Nelson, P. J. Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm an d implications for in vivo immunoregulation. Cycling of human dendritic cel l effector phenotypes in response to TNF-alpha modification of the current 'maturation' paradigm and implications for in vivo immunoregulation.